U.S. Dietary Supplements Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

U.S. Dietary Supplements Market Size Analysis and Top Companies

The global U.S. dietary supplements market size is estimated to hit around USD 162.40 billion by 2033, increasing from USD 65.70 billion in 2023 with a CAGR of 9.47% from 2023 to 2033. The top companies operating in the U.S. dietary supplements market are Bayer, NBTY Inc, Bionova Lifesciences, Nu Skin Enterprises, Carlyle Group, Pfizer, Arkopharma Laboratoires Pharmaceutiques, Glanbia, Herbalife International, Abbott Laboratories, GlaxoSmithKline, Nature’s Sunshine Forms, Amway, Archer Daniels Midland, and Others.

Market Report Coverage

U.S. Dietary Supplements Key Players

• Bayer
• NBTY Inc
• Bionova Lifesciences
• Nu Skin Enterprises
• Carlyle Group
• Pfizer
• Arkopharma Laboratoires Pharmaceutiques
• Glanbia
• Herbalife International
• Abbott Laboratories
• GlaxoSmithKline
• Nature’s Sunshine Forms
• Amway
• Archer Daniels Midland

Recent Developments

• In September 2024, Bonafide Health, LLC (Bonafide Health), an indirect subordinate of the Harrison New York., and Otsuka Pharmaceutical Co., Ltd. (Otsuka) launched Thermella™, a plant-based supplement that helps in the contribution of women’s health during menopause. 
• In June 2024, Bausch + Lomb introduced Blink NutriTears, an over-the-counter supplement that helps target the cause of dry eye disease and enhances healthy tear production. 

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344